Argent Capital Management Has Boosted Ferro (FOE) Stake; Medpace Holdings (MEDP) Sellers Decreased By 1.45% Their Shorts

November 15, 2017 - By Vivian Currie

Argent Capital Management Llc increased Ferro Corporation (FOE) stake by 48.3% reported in 2017Q2 SEC filing. Argent Capital Management Llc acquired 56,375 shares as Ferro Corporation (FOE)’s stock rose

20.45%. The Argent Capital Management Llc holds 173,095 shares with $3.17 million value, up from 116,720 last quarter. Ferro Corporation now has $1.95 billion valuation. The stock increased 0.04% or $0.01 on November 14, reaching $23.24. About shares traded. Ferro Corporation (NYSE:FOE) has risen 24.49% since November 15, 2016 and is uptrending. It has outperformed by 7.79% the S&P500.

Medpace Holdings Incorporated (NASDAQ:MEDP) had a decrease of 1.45% in short interest. MEDP’s SI was 761,600 shares in November as released by FINRA. Its down 1.45% from 772,800 shares previously. With 105,200 avg volume, 7 days are for Medpace Holdings Incorporated (NASDAQ:MEDP)’s short sellers to cover MEDP’s short positions. The SI to Medpace Holdings Incorporated’s float is 10.46%. It closed at $34.12 lastly. It is down 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 6 analysts covering Ferro (NYSE:FOE), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ferro had 13 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Ferro Corporation (NYSE:FOE) earned “Overweight” rating by KeyBanc Capital Markets on Friday, November 10. On Thursday, October 12 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The rating was upgraded by Seaport Global on Wednesday, January 13 to “Buy”. Deutsche Bank maintained the shares of FOE in report on Monday, July 31 with “Buy” rating. The firm earned “Accumulate” rating on Wednesday, August 12 by Global Hunter Securities. Oppenheimer initiated it with “Outperform” rating and $16 target in Wednesday, September 23 report. The company was downgraded on Tuesday, August 4 by Zacks. The rating was upgraded by Longbow to “Buy” on Monday, June 5. The firm has “Buy” rating given on Friday, September 1 by KeyBanc Capital Markets.

Argent Capital Management Llc decreased Mattel Inc. (NASDAQ:MAT) stake by 88,232 shares to 393,922 valued at $8.48 million in 2017Q2. It also reduced Lgi Homes Inc. (NASDAQ:LGIH) stake by 52,565 shares and now owns 40,360 shares. Pfizer Inc. (NYSE:PFE) was reduced too.

Investors sentiment increased to 1.06 in 2017 Q2. Its up 0.04, from 1.02 in 2017Q1. It improved, as 17 investors sold FOE shares while 63 reduced holdings. 33 funds opened positions while 52 raised stakes. 79.65 million shares or 1.21% more from 78.69 million shares in 2017Q1 were reported. Price T Rowe Assoc Md has 50,493 shares. Jennison Associates Ltd Liability invested 0.08% in Ferro Corporation (NYSE:FOE). Quantitative Invest Mgmt Lc invested in 151,400 shares. Creative Planning has invested 0% in Ferro Corporation (NYSE:FOE). Texas-based Hbk Invests Limited Partnership has invested 0.02% in Ferro Corporation (NYSE:FOE). Skyline Asset Mgmt LP has 1.40 million shares. State Street holds 1.61M shares. 28,381 were reported by Fifth Third Bancshares. Nationwide Fund Advsrs reported 0.01% of its portfolio in Ferro Corporation (NYSE:FOE). Broadview Advsr Ltd holds 1.87% of its portfolio in Ferro Corporation (NYSE:FOE) for 692,828 shares. Federated Investors Inc Pa owns 39,370 shares. California-based Nicholas Invest Ltd Partnership has invested 0.34% in Ferro Corporation (NYSE:FOE). Jpmorgan Chase Com reported 1.51 million shares stake. Dana Inv Advsrs Inc stated it has 0.11% of its portfolio in Ferro Corporation (NYSE:FOE). Walleye Trading Ltd Liability Co invested 0% of its portfolio in Ferro Corporation (NYSE:FOE).


Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: